ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PRLD Prelude Therapeutics Inc

4.07
0.03 (0.74%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Prelude Therapeutics Inc PRLD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 0.74% 4.07 10:00:00
Open Price Low Price High Price Close Price Previous Close
4.04 3.99 4.07 4.07 4.04
more quote information »

Recent News

Date Time Source Heading
10/4/202406:35GLOBEPrelude Highlights Continued Strength of Discovery Engine at..
06/3/202408:45GLOBEPrelude Announces Acceptance of Multiple Preclinical..
05/3/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202410:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202410:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202410:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202409:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202408:05GLOBEPrelude Therapeutics to Participate in Barclays Global..
16/2/202409:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202408:22EDGAR2Form 8-K - Current report
16/2/202408:05GLOBEPrelude Therapeutics Reports Full Year 2023 Financial..
13/2/202408:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202301:34GLOBEPrelude Therapeutics Announces $25 Million Private Placement
12/12/202301:17EDGAR2Form 8-K - Current report
02/11/202307:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202307:23EDGAR2Form 8-K - Current report
02/11/202307:10GLOBEPrelude Announces Strategic Pipeline Progress and Updates,..
02/11/202307:05GLOBEPrelude Therapeutics and AbCellera Enter Partnership to..
15/10/202303:30GLOBEPrelude Announces Multiple Clinical and Preclinical Poster..
07/10/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:30GLOBEPrelude Therapeutics to Participate in Three Healthcare..
03/8/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:10EDGAR2Form 8-K - Current report
03/8/202322:00GLOBEPrelude Therapeutics Announces Second Quarter 2023 Financial..
07/7/202306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202322:30GLOBEPrelude Therapeutics To Participate in Jefferies Healthcare..
18/5/202321:00GLOBEPrelude Therapeutics Announces Pricing of Public Offering
18/5/202306:08GLOBEPrelude Therapeutics Announces Launch of Proposed Public..
08/5/202322:30GLOBEPrelude Therapeutics Announces First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock